Menu

CPTR: Accelerating a new paradigm

Perspectives on the urgency of CPTR's mission and ongoing efforts

Perspectives

thumb-mario

Mario Raviglione on Coordinating Research to End TB

Coordinating new TB treatments and diagnostics, and a sustainable approach to End TB

thumb-martha2

Martha Brumfield on the Success and Continued Growth of CPTR

How CPTR has grown into a vital and innovative catalyst in the fight against TB

thumb-fauci

US NIAID’s Anthony Fauci on Halting Drug Resistance

New TB drug regimens and diagnostics are needed to fight TB and MDR-TB

News

sitenews-2016-meeting

Save the Date: CPTR 2016 Workshop, April 4 – 7

Theme: Evolving TB drug regimen and diagnostic development: Where innovation meets implementation Date: April 4-7, 2016 Location: Omni Shoreham Hotel, Washington, DC Additional information, including agenda, speakers, etc. will be updated to this page when available

December 21, 2015 Events CPTR Workshop 2016
sitenews-CPTR-WHO

CPTR and WHO Partner to Improve Understanding of Past Phase III TB Drug Trials

CPTR and the WHO Global TB Programme have partnered to help maximize the knowledge and understanding gained from completed Phase III TB drug clinical trials. The partnership will bring together an expert steering committee to analyze three contemporary Phase III trials (REMox TB, Rifaquin, and OFLOTUB). The collaboration will improve the drug development community’s understanding […]

December 21, 2015 Drug Development clinical trials fluroquinolones

From the Working Groups

Modeling & Simulation Workgroup (M&S-WG) Q4-2015 Update

Working closely with the Data Standards and Integration Workgroup (DSI-WG), the M&S-WG uses aggregated clinical trial data to create robust empirical, mechanistic, and systems biology models and quantitative simulation tools to facilitate TB drug and drug regimen development.

January 22, 2016

Data Standards & Integration Workgroup (DSI-WG) Q4-2015 Update

The DSI-WG provides the information technology (IT) infrastructure to support all CPTR data needs for developing regulatory science tools and methods to enable development of new TB drugs, drug regimens, and diagnostics. Aggregating all relevant data in a secure database for analysis by the CPTR Workgroups and authorized researchers is a key focus for this […]

January 22, 2016

Pre-Clinical and Clinical Sciences Workgroup (PCS-WG) Q4-2015 Update

The PCS-WG is focused on the evidence-based evaluation of translational tools to support effective decision-making and advance new agents from the pre-clinical to clinical development space.  These tools represent innovative approaches to address pre-clinical issues, including pre-clinical in vitro and in vivo efficacy, pre-clinical drug safety, and toxicology, pre-clinical PK/PD analyses involving the use of […]

January 22, 2016
About CPTR

Through partnership, CPTR speeds the development of new and markedly improved drug regimens for tuberculosis.